Recent research shows genetic variants in GLP-1 receptor (GLP1R), GIPR, and metabolic genes influence how your body responds to these peptides. A one-size approach often leads to suboptimal dosing or side effect burden.
Receptor genetics: why the same drug produces different outcomes. Mounjaro exerts its effects by targeting two receptors: GLP-1R and GIPR. These receptors play a central role in regulating blood glucose, appetite, lipid metabolism, and overall energy balance.
"Our findings suggest that GLP-1-based therapies effectively target gut and brain pathways involved in feeding and metabolism, even in the context of a complex genetic disorder like BBS," said first author Arashdeep Singh, PhD, former Monell Research Associate.
Key takeaways: GLP-1 receptor agonist use before pregnancy was tied to lower risks for hypertensive disorders of pregnancy and gestational diabetes.
That last part is the key. GLP-1 receptor agonists dont just work in your stomach. They cross the blood-brain barrier and act on receptors throughout the central nervous system, including regions involved in reward processing, motivation, and emotional regulation.
